Skip to main content
. Author manuscript; available in PMC: 2012 May 15.
Published in final edited form as: J Am Chem Soc. 2010 Nov 15;132(48):17247–17257. doi: 10.1021/ja107153a

Figure 6.

Figure 6

FITC-octavalent anti-CD3 CSANs bound to CD3+ HPB-MLT cells (a) but not to CD3- Daudi cells (b). HPB-MLT cells or Daudi cells were incubated with FITC-antiCD19 mAb or FITC-octavalent anti-CD3 CSANs at 37°C for 30 mins. FITC-antiCD19 mAb was used as positive control bound to Daudi cells. The fluorescence of bound FITC-antiCD19 mAb or FITC- octavalent anti-CD3 CSANs was analyzed by flow cytometry. The horizontal axis of the diagram represents the fluorescent intensity, and the vertical axis shows the percentage of maximum cell number.